SCIENCE VALLEY

RESEARCH INSTITUTE

Tech Science® for life.

Science Valley is a multicentric management company, which offers intelectual and technical scientific services in the field of intelligence in clinical research and R&D services for the development of pharmaceutical drugs, raw materials, new treatments, high medical-scientific education, surgical procedures, vaccines, cost-effectiveness studies and devices for human health.

Science Valley

Technology and innovation to promote the improvement in healthcare and save the lives of patients with severe diseases.

GET TO KNOW OUR STORY

Science Valley works in an integrated manner in the clinical study processes that will serve as the basis for the following steps:

1

Study design, planning, management and biopharmaceutial tests execution

2

Recruitment, data management and preventive monitoring of trial patients

3

Technical regulatory support for protocols approvals, registration, manufacturing and marketing

4

Pre-clinical, clinical research and R&D to create new drugs, molecules, innovative treatments and pharmacovigilance

5

Paper publications of clinical studies and scientific articles in renowned scientific journals

WANT TO KNOW MORE?
WRITE TO US

29 RESEARCH
CENTERS

Twenty nine qualified “Research Centers” in twelve states, skilled to manage all four phases of the Clinical Trials processes (Phase 1, 2, 3 and 4) and in some cases, even Preclinical studies, supporting all the Healthcare community & Pharma Industry (sponsors, physicians, institutions and researchers).

QUALITY
AND SUPPORT

High quality standards in study design, planning and execution of trials, Academic Studies, data treatment and publications, in addition to all related R&D and support for development and Registry of new Pharma drugs, molecules and innovative treatments.

BEST PRACTICES
IN RESEARCH

Operational guideline in light of “Good Practices in Research” and Compliance with its all related regulatory affairs (FDA/ANVISA). High quality in recruitment and monitoring of patients panel. Huge track record results and important publications with more than 90 studies with 3000 patients.

LONG-TERM
MULTICENTRIC VIEW

Up to 2026, we aim to become the best and greatest Multicenter International Research Institute (MIRI) for Biotechnological areas of interests: RNA, mAbs and Recombinant Proteins focused on Oncology, Cardiology, Endocrinology, Neurology and COVID in addition of Medical Gadgets/Devices.